skip to main content


Title: Plasmon-enhanced Quantum Emission from Spin Defects in Two-dimensional Hexagonal Boron Nitride

We demonstrate 120-fold photoluminescence enhancement of VB-spin defects in hBN by coupling them to nanopatch antennas. Since the laser spot is 6.25 times larger than the antenna area, the actual enhancement is 750-fold.

 
more » « less
Award ID(s):
2015025
NSF-PAR ID:
10348796
Author(s) / Creator(s):
; ; ; ; ; ; ; ; ; ; ; ;
Date Published:
Journal Name:
CLEO: QELS_Fundamental Science 2022
Page Range / eLocation ID:
FF3C.3
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. We report a 250-fold photoluminescence enhancement of VB-spin-defects in hBN by coupling them to nanopatch antennas (NPA). Considering the relative size of the NPAs and laser-spot, an actual enhancement of 1695 times is determined.

     
    more » « less
  2. Abstract

    We report a new approach to monitor drug release from nanocarriers via a paclitaxel–methylene blue conjugate (PTX‐MB) with redox activity. This construct is in a photoacoustically silent reduced state inside poly(lactic‐co‐glycolic acid) (PLGA) nanoparticles (PTX‐MB@PLGA NPs). During release, PTX‐MB is spontaneously oxidized to produce a concentration‐dependent photoacoustic signal. An in vitro drug‐release study showed an initial burst release (25 %) between 0–24 h and a sustained release between 24–120 h with a cumulative release of 40.6 % and a 670‐fold increase in photoacoustic signal. An in vivo murine drug release showed a photoacoustic signal enhancement of up to 649 % after 10 hours. PTX‐MB@PLGA NPs showed an IC50of 78 μg mL−1and 44.7±4.8 % decrease of tumor burden in an orthotopic model of colon cancer via luciferase‐positive CT26 cells.

     
    more » « less
  3. Abstract

    We report a new approach to monitor drug release from nanocarriers via a paclitaxel–methylene blue conjugate (PTX‐MB) with redox activity. This construct is in a photoacoustically silent reduced state inside poly(lactic‐co‐glycolic acid) (PLGA) nanoparticles (PTX‐MB@PLGA NPs). During release, PTX‐MB is spontaneously oxidized to produce a concentration‐dependent photoacoustic signal. An in vitro drug‐release study showed an initial burst release (25 %) between 0–24 h and a sustained release between 24–120 h with a cumulative release of 40.6 % and a 670‐fold increase in photoacoustic signal. An in vivo murine drug release showed a photoacoustic signal enhancement of up to 649 % after 10 hours. PTX‐MB@PLGA NPs showed an IC50of 78 μg mL−1and 44.7±4.8 % decrease of tumor burden in an orthotopic model of colon cancer via luciferase‐positive CT26 cells.

     
    more » « less
  4. Abstract

    Porphyromonas gingivalisis a keystone pathogen in periodontal disease. We herein report a dual‐modal fluorescent and photoacoustic imaging probe for the detection of gingipain proteases secreted byP. gingivalis. Upon proteolytic cleavage by Arg‐specific gingipain (RgpB), five‐fold photoacoustic enhancement and >100‐fold fluorescence activation was measured with detection limits of 1.1 nM RgpB and 5.0E4 CFU mL−1bacteria in vitro. RgpB activity was imaged in porcine jaws with low‐nanomolar sensitivity. Diagnostic efficacy was evaluated in gingival crevicular fluid samples from subjects with and without periodontal disease, wherein activation was correlated to qPCR‐based detection ofP. gingivalis(Pearson'sr=0.71). Finally, photoacoustic imaging of RgpB‐cleaved probe was achieved in murine brains ex vivo, with relevance and potential utility for disease models of general infection byP. gingivalis, motivated by the recent biological link between gingipain and Alzheimer's disease.

     
    more » « less
  5. Abstract

    Porphyromonas gingivalisis a keystone pathogen in periodontal disease. We herein report a dual‐modal fluorescent and photoacoustic imaging probe for the detection of gingipain proteases secreted byP. gingivalis. Upon proteolytic cleavage by Arg‐specific gingipain (RgpB), five‐fold photoacoustic enhancement and >100‐fold fluorescence activation was measured with detection limits of 1.1 nM RgpB and 5.0E4 CFU mL−1bacteria in vitro. RgpB activity was imaged in porcine jaws with low‐nanomolar sensitivity. Diagnostic efficacy was evaluated in gingival crevicular fluid samples from subjects with and without periodontal disease, wherein activation was correlated to qPCR‐based detection ofP. gingivalis(Pearson'sr=0.71). Finally, photoacoustic imaging of RgpB‐cleaved probe was achieved in murine brains ex vivo, with relevance and potential utility for disease models of general infection byP. gingivalis, motivated by the recent biological link between gingipain and Alzheimer's disease.

     
    more » « less